.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Argus Health
Covington
McKinsey
Johnson and Johnson
Dow
Citi
Farmers Insurance
Julphar
Deloitte

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090480

« Back to Dashboard

NDA 090480 describes MUPIROCIN, which is a drug marketed by Glenmark Pharms Inc, Fougera Pharms, Glenmark Pharms, Perrigo New York, Taro, and Teva, and is included in six NDAs. It is available from twenty-seven suppliers. Additional details are available on the MUPIROCIN profile page.

The generic ingredient in MUPIROCIN is mupirocin. There are twelve drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the mupirocin profile page.

Summary for 090480

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 090480

Mechanism of ActionRNA Synthetase Inhibitors

Medical Subject Heading (MeSH) Categories for 090480

Suppliers and Packaging for NDA: 090480

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MUPIROCIN mupirocin OINTMENT;TOPICAL 090480 ANDA A-S Medication Solutions 50090-0898 50090-0898-0 22 g in 1 TUBE (50090-0898-0)
MUPIROCIN mupirocin OINTMENT;TOPICAL 090480 ANDA Unit Dose Services 50436-0180 50436-0180-1 22 g in 1 TUBE (50436-0180-1)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength2%
Approval Date:Jun 8, 2011TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cerilliant
Daiichi Sankyo
Moodys
Baxter
Julphar
Chinese Patent Office
Dow
Accenture
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot